92 related articles for article (PubMed ID: 28223415)
21. Inhibition of Proliferation and Epithelial Mesenchymal Transition in Retinal Pigment Epithelial Cells by Heavy Chain-Hyaluronan/Pentraxin 3.
He H; Kuriyan AE; Su CW; Mahabole M; Zhang Y; Zhu YT; Flynn HW; Parel JM; Tseng SC
Sci Rep; 2017 Mar; 7():43736. PubMed ID: 28252047
[TBL] [Abstract][Full Text] [Related]
22. T helper responses are maintained by basal-like breast cancer cells and confer to immune modulation via upregulation of PD-1 ligands.
Karasar P; Esendagli G
Breast Cancer Res Treat; 2014 Jun; 145(3):605-14. PubMed ID: 24816762
[TBL] [Abstract][Full Text] [Related]
23. Activated-PAK4 predicts worse prognosis in breast cancer and promotes tumorigenesis through activation of PI3K/AKT signaling.
He LF; Xu HW; Chen M; Xian ZR; Wen XF; Chen MN; Du CW; Huang WH; Wu JD; Zhang GJ
Oncotarget; 2017 Mar; 8(11):17573-17585. PubMed ID: 28407679
[TBL] [Abstract][Full Text] [Related]
24. Protein expression and methylation of DNA repair genes hMLH1, hMSH2, MGMT and BRCA1 and their correlation with clinicopathological parameters and prognosis in basal-like breast cancer.
Alkam Y; Mitomi H; Nakai K; Himuro T; Saito T; Takahashi M; Arakawa A; Yao T; Saito M
Histopathology; 2013 Nov; 63(5):713-25. PubMed ID: 24004112
[TBL] [Abstract][Full Text] [Related]
25. Long pentraxin-3 as an epithelial-stromal fibroblast growth factor-targeting inhibitor in prostate cancer.
Ronca R; Alessi P; Coltrini D; Di Salle E; Giacomini A; Leali D; Corsini M; Belleri M; Tobia C; Garlanda C; Bonomi E; Tardanico R; Vermi W; Presta M
J Pathol; 2013 Jun; 230(2):228-38. PubMed ID: 23424081
[TBL] [Abstract][Full Text] [Related]
26. Amplification of SOX4 promotes PI3K/Akt signaling in human breast cancer.
Mehta GA; Parker JS; Silva GO; Hoadley KA; Perou CM; Gatza ML
Breast Cancer Res Treat; 2017 Apr; 162(3):439-450. PubMed ID: 28176176
[TBL] [Abstract][Full Text] [Related]
27. FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer.
Cai J; Tian AX; Wang QS; Kong PZ; Du X; Li XQ; Feng YM
Cancer Lett; 2015 Oct; 367(2):129-37. PubMed ID: 26210254
[TBL] [Abstract][Full Text] [Related]
28. Identification of EGF-NF-κB-FOXC1 signaling axis in basal-like breast cancer.
Chung S; Jin Y; Han B; Qu Y; Gao B; Giuliano AE; Cui X
Cell Commun Signal; 2017 Jun; 15(1):22. PubMed ID: 28629477
[TBL] [Abstract][Full Text] [Related]
29. PTX3 promotes breast cancer cell proliferation and metastasis by regulating PKCζbreast cancer, pentraxin 3, protein kinase Cζ, proliferation, metastasis.
Wu J; Yang R; Ge H; Zhu Y; Liu S
Exp Ther Med; 2024 Mar; 27(3):124. PubMed ID: 38410189
[TBL] [Abstract][Full Text] [Related]
30. Pentraxin 3: a novel biomarker for predicting progression from prostatic inflammation to prostate cancer.
Stallone G; Cormio L; Netti GS; Infante B; Selvaggio O; Fino GD; Ranieri E; Bruno F; Prattichizzo C; Sanguedolce F; Tortorella S; Bufo P; Grandaliano G; Carrieri G
Cancer Res; 2014 Aug; 74(16):4230-8. PubMed ID: 24950910
[TBL] [Abstract][Full Text] [Related]
31. PTX3, a key component of innate immunity, is induced by SAA via FPRL1-mediated signaling in HAECs.
Dong Z; An F; Wu T; Zhang C; Zhang M; Zhang Y; An G; An F
J Cell Biochem; 2011 Aug; 112(8):2097-105. PubMed ID: 21465531
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of the inflammatory factor pentraxin-3 suppresses growth and invasion of lung adenocarcinoma through the AKT and NF-kappa B pathways.
Hu FQ; Qiao T; Xie X; Hu R; Xiao HB
J Biol Regul Homeost Agents; 2014; 28(4):649-57. PubMed ID: 25620175
[TBL] [Abstract][Full Text] [Related]
33. Does the PI3K pathway play a role in basal breast cancer?
Moulder SL
Clin Breast Cancer; 2010 Nov; 10 Suppl 3():S66-71. PubMed ID: 21115424
[TBL] [Abstract][Full Text] [Related]
34. Upregulated WDR26 serves as a scaffold to coordinate PI3K/ AKT pathway-driven breast cancer cell growth, migration, and invasion.
Ye Y; Tang X; Sun Z; Chen S
Oncotarget; 2016 Apr; 7(14):17854-69. PubMed ID: 26895380
[TBL] [Abstract][Full Text] [Related]
35. [Relationship between epithelial-mesenchymal transition and basal cell-like phenotype in breast cancer].
Wu WX; Zhang YP; Wen XW; Lu N; Tang ZY; Zhang Y; Wang Z; Wang W; Yang HJ
Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):519-23. PubMed ID: 20021961
[TBL] [Abstract][Full Text] [Related]
36. M-ficolin interacts with the long pentraxin PTX3: a novel case of cross-talk between soluble pattern-recognition molecules.
Gout E; Moriscot C; Doni A; Dumestre-Pérard C; Lacroix M; Pérard J; Schoehn G; Mantovani A; Arlaud GJ; Thielens NM
J Immunol; 2011 May; 186(10):5815-22. PubMed ID: 21490156
[TBL] [Abstract][Full Text] [Related]
37. Elevated levels of the long pentraxin 3 in paracetamol-induced human acute liver injury.
Craig DG; Lee P; Pryde EA; Walker SW; Beckett GJ; Hayes PC; Simpson KJ
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):359-67. PubMed ID: 23169308
[TBL] [Abstract][Full Text] [Related]
38. ErbB2-overexpressing human mammary carcinoma cells display an increased requirement for the phosphatidylinositol 3-kinase signaling pathway in anchorage-independent growth.
Hermanto U; Zong CS; Wang LH
Oncogene; 2001 Nov; 20(51):7551-62. PubMed ID: 11709727
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of genes for C-reactive protein and related pentraxin/complement proteins in photodynamic therapy-treated human tumor cells: enrolment of PI3K/Akt and AP-1.
Merchant S; Korbelik M
Immunobiology; 2013 Jun; 218(6):869-74. PubMed ID: 23182717
[TBL] [Abstract][Full Text] [Related]
40. Pentraxin-3 Silencing Suppresses Gastric Cancer-related Inflammation by Inhibiting Chemotactic Migration of Macrophages.
Choi B; Lee EJ; Park YS; Kim SM; Kim EY; Song Y; Kang SW; Rhu MH; Chang EJ
Anticancer Res; 2015 May; 35(5):2663-8. PubMed ID: 25964543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
